# Hydroxyurea With or Without Imatinib Mesylate in Treating Patients With Recurrent or Progressive Meningioma

> **NCT00904735** · PHASE2 · UNKNOWN · sponsor: **Istituto Scientifico H. San Raffaele** · enrollment: 76 (estimated)

## Conditions studied

- Brain and Central Nervous System Tumors

## Interventions

- **DRUG:** hydroxyurea
- **DRUG:** imatinib mesylate

## Key facts

- **NCT ID:** NCT00904735
- **Lead sponsor:** Istituto Scientifico H. San Raffaele
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-06
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2013-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00904735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00904735, "Hydroxyurea With or Without Imatinib Mesylate in Treating Patients With Recurrent or Progressive Meningioma". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00904735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*